Evidence map›Paper›PMID 25197653›Full record

ArticleBioMed research international2014

The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease.

Carla Loreto, Giampiero La Rocca, Rita Anzalone, Rosario Caltabiano, Giuseppe Vespasiani, Sergio Castorina, David J Ralph, Selim Cellek, Giuseppe Musumeci, Salvatore Giunta and 3 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 132 citations in OpenAlex.

  1. Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Frontiers in pharmacology · 2023
    Article
  10. Nano-TRAIL: a promising path to cancer therapy.Cancer drug resistance (Alhambra, Calif.) · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Downregulation of PTEN Promotes AutophagyFrontiers in cardiovascular medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Carla LoretoDepartment of Bio-Medical Sciences, Anatomy and Histology Section, University of Catania, Via S. Sofia 87, 95123 Catania, Italy.
Giampiero La RoccaDepartment of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90100 Palermo, Italy.ORCID 0000-0002-1334-5054
Rita AnzaloneDepartment of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90100 Palermo, Italy.ORCID 0000-0002-3620-2507
Rosario CaltabianoDepartment G.F. Ingrassia Section of Anatomic Pathology University of Catania, 95123 Catania, Italy.
Giuseppe VespasianiDepartment of Urology, School of Medicine Tor Vergata University of Rome, 00133 Rome, Italy.
Sergio CastorinaDepartment of Bio-Medical Sciences, Anatomy and Histology Section, University of Catania, Via S. Sofia 87, 95123 Catania, Italy.
David J RalphUniversity College London Hospital, London WC1E 6BT, UK.
Selim CellekCranfield Health Cranfield University, MK43 0AL, UK.ORCID 0000-0002-4856-285X
Giuseppe MusumeciDepartment of Bio-Medical Sciences, Anatomy and Histology Section, University of Catania, Via S. Sofia 87, 95123 Catania, Italy.
Salvatore GiuntaDepartment of Bio-Medical Sciences, Anatomy and Histology Section, University of Catania, Via S. Sofia 87, 95123 Catania, Italy.ORCID 0000-0002-8095-8678
Rados DjinovicSava Perovic Foundation, Center for Genito-Urinary Reconstructive Surgery, 11000 Belgrade, Serbia.
Dragoslav BasicClinic of Urology, Clinical Center Nis, 18000 Nis, Serbia.ORCID 0000-0001-8746-960X
Salvatore SansaloneDepartment of Urology, School of Medicine Tor Vergata University of Rome, 00133 Rome, Italy.
University of Catania · ITUniversity of Palermo · ITUniversity of Rome Tor Vergata · ITCranfield University · GBUniversity College Hospital · GBUniversity of Nis · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peyronie's disease (PD) is characterized with formation of fibrous plaques which result in penile deformity, pain, and erectile dysfunction. The aim of this study was to investigate the activation of the intrinsic apoptotic pathway in plaques from PD patients. Tunica albuginea from either PD or control patients was assessed for the expression of bax, bcl-2 and caspases 9 and 3 using immunohistochemistry and by measurement of apoptotic cells using TUNEL assay. Bax overexpression was observed in metaplastic bone tissue, in fibroblasts, and in myofibroblast of plaques from PD patients. Little or no bcl-2 immunostaining was detected in samples from either patients or controls. Caspase 3 immunostaining was very strong in fibrous tissue, in metaplasic bone osteocytes, and in primary ossification center osteoblasts. Moderate caspase 9 immunostaining was seen in fibrous cells plaques and in osteocytes and osteoblasts of primary ossification centers from PD patients. Control samples were negative for caspase 9 immunostaining. In PD patients the TUNEL immunoassay showed intense immunostaining of fibroblasts and myofibroblasts, the absence of apoptotic cells in metaplasic bone tissue and on the border between fibrous and metaplastic bone tissue. Apoptosis occurs in stabilized PD plaques and is partly induced by the intrinsic pathway.

Indexed as

ApoptosisDisease ProgressionSignal TransductionAdultAgedbcl-2-Associated X ProteinCaspase 3Caspase 9HumansIn Situ Nick-End LabelingMaleMiddle AgedPenile IndurationStaining and LabelingYoung Adultbcl-2-Associated X ProteinCaspase 3Caspase 9

Identifiers

PMID25197653
PMCPMC4147380
OpenAlexW1973666710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.